Comparison of transcranial sonography, magnetic resonance imaging, and single photon emission computed tomography findings in idiopathic spasmodic torticollis

Various lines of evidence suggest that the basal ganglia and thalamus are involved in the pathogenesis of idiopathic dystonia, but unfortunately neuroradiological and pathological data are sparse and controversial. In this study, we have examined 10 patients with spasmodic torticollis by neuroimaging techniques, including transcranial sonography (TS; n = 10), conventional (n = 10) and diffusion‐weighted (n = 5) magnetic resonance imaging (MRI), and single photon emission computed tomography (SPECT; n = 10), employing [123I]iodobenzamide (IBZM) as a ligand with a high affinity to the D2 receptor. In seven patients, TS showed small hyperechogenic lesions in the medial segments of the lentiform nucleus contralateral to the side of head deviation. In accordance with the site of TS abnormalities, diffusion‐weighted MRI displayed a hyperintense lesion in only one patient, while standard MRI of this area was normal in all patients. SPECT revealed a slight but statistically nonsignificant reduction of IBZM tracer uptake in an area corresponding to the dorsal portions of the striatum in 9 of the 10 patients. TS findings support the hypothesis that structural alterations of the pallidothalamic circuit contralateral to the side of head deviation are involved in the pathogenesis of idiopathic spasmodic torticollis. TS may be more sensitive in detecting basal ganglia alterations than MRI.

[1]  S. Asenbaum,et al.  Dopamine D2 receptor imaging and measurement with SPECT. , 1993, Advances in neurology.

[2]  J. Krauss,et al.  Dystonia following head trauma: A report of nine patients and review of the literature , 1992, Movement disorders : official journal of the Movement Disorder Society.

[3]  U. Bogdahn,et al.  Reduced echogenicity of brainstem raphe specific to unipolar depression: A transcranial color-coded real-time sonography study , 1995, Biological Psychiatry.

[4]  T. Chase,et al.  Positron emission tomographic studies of regional cerebral glucose metabolism in idiopathic dystonia. , 1988, Advances in neurology.

[5]  G Becker,et al.  Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography , 1995, Neurology.

[6]  MRI pathology of basal ganglia in dystonic disorders. , 1993, Advances in neurology.

[7]  B. Pasamanick,et al.  Idiopathic dystonia musculorum deformans , 1960, Neurology.

[8]  H. Kung,et al.  A kit formulation for preparation of iodine-123-IBZM: a new CNS D-2 dopamine receptor imaging agent. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  C. Marsden,et al.  The anatomical basis of symptomatic hemidystonia. , 1985, Brain : a journal of neurology.

[10]  D. Price,et al.  Primary dystonias: a review of the pathology and suggestions for new directions of study. , 1988, Advances in neurology.

[11]  H. Karbe,et al.  Positron emission tomography demonstrates frontal cortex and basal ganglia hypometabolism in dystonia , 1992, Neurology.

[12]  A. Lang,et al.  Positron tomography in dystonia. , 1988, Advances in neurology.

[13]  A. Alavi,et al.  In vitro and in vivo evaluation of [123I]IBZM: a potential CNS D-2 dopamine receptor imaging agent. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  C D Marsden,et al.  Dystonia after head trauma , 1994, Neurology.

[15]  C. Marsden,et al.  Brain dopaminergic system studied in patients with dystonia using positron emission tomography. , 1988, Advances in neurology.

[16]  G Becker,et al.  Transcranial color-coded real-time sonography in adults. , 1990, Stroke.

[17]  J. Jankovic,et al.  Hemidystonia: a report of 22 patients and a review of the literature. , 1985, Journal of neurology, neurosurgery, and psychiatry.

[18]  Jens Frahm,et al.  Rapid NMR imaging of molecular self-diffusion using a modified CE-FAST sequence , 1989 .

[19]  J. Jankovic,et al.  Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[20]  C. Marsden,et al.  Pathological report of four patients presenting with cranial dystonias , 1988, Movement disorders : official journal of the Movement Disorder Society.

[21]  H. Teräväinen,et al.  Dementia and treatment with L‐dopa in Parkinson's disease , 1988, Movement disorders : official journal of the Movement Disorder Society.

[22]  N. Verhoeff,et al.  Estimation of dopamine D2 receptor binding potential in the striatum with iodine-123-IBZM SPECT: technical and interobserver variability. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  U. Bogdahn,et al.  Identification of Ventricular Enlargement and Estimation of Intracranial Pressure by Transcranial Color‐Coded Real‐Time Sonography , 1994, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[24]  J. E. Tanner,et al.  Spin diffusion measurements : spin echoes in the presence of a time-dependent field gradient , 1965 .

[25]  M. S. Lee,et al.  Movement disorders following lesions of the thalamus or subthalamic region , 1994, Movement disorders : official journal of the Movement Disorder Society.

[26]  G. Deuschl,et al.  Prolonged MRI T2 times of the lentiform nucleus in idiopathic spasmodic torticollis , 1994, Neurology.

[27]  U Keske,et al.  Dopamine D2 receptor imaging with iodine-123-iodobenzamide SPECT in idiopathic rotational torticollis. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[28]  D. Price,et al.  Pathology in brainstem regions of individuals with primary dystonia , 1988, Neurology.